A Place Where Precision Meets the Need for Continuity
Chemotherapy and targeted treatments are selected according to receptor status and molecular profile, with regimens adjusted to reduce cumulative toxicity.
Carter Wilson 
The appearance of a malignant change in glandular tissue is never abstract. It arrives inside a life already in motion. TomoClinic answers that reality with a framework of care designed to be both technically exact and personally steady. The aim is not only to address the disease but to keep the woman present in her own story.
Who We Are
The center was formed to bring together the most advanced radiotherapy available anywhere in Ukraine with a team that refuses to treat patients as isolated cases. Oncologists, breast surgeons, radiation specialists, and chemotherapists sit together as a tumor board for every treatment plan. Their shared standard is international evidence applied with local attentiveness. The presence of TomoTherapy HD allows radiation fields of complex geometry to be delivered in a continuous helical motion, something previously unavailable in the country. Experience is measured not only in numbers of cases but in the consistency of outcomes and the quality of daily attention.
What We Offer
Care begins with thorough imaging and tissue diagnosis and continues through every subsequent stage. Organ-sparing surgery is offered whenever oncological principles permit; when removal is required, immediate or delayed reconstruction is planned with equal care. Radiation therapy is performed on both conventional linear accelerators and the TomoTherapy HD platform, the latter particularly valuable for irregular volumes or when previous radiation has limited further options. Chemotherapy and targeted treatments are selected according to receptor status and molecular profile, with regimens adjusted to reduce cumulative toxicity. Supportive services run alongside active treatment so that the physical and emotional load remains manageable.
When It’s Useful
The clinic is the natural choice when early detection has revealed a small lesion that still allows breast conservation. It is equally appropriate when the disease is more advanced and radiation must reach residual or regional targets with high conformity. Women carrying genetic risk who require risk-reducing surgery find a surgical team prepared for simultaneous reconstruction. Those whose previous treatment has left residual disease or who face recurrent disease benefit from the ability to re-irradiate selected areas safely. The center also serves patients who simply wish every decision to be examined by several specialists before any irreversible step is taken.
Why Choose Us
Distinction lies in the refusal to separate technology from judgment. Equipment unique to Ukraine is matched by a daily practice of verification and collective review. Healthy tissue is protected by design, not by hope. Plans are revised when new findings appear. The patient remains visible throughout, not as a case number but as the constant reference point of every discussion.
Call to Action
Learn more about the diagnostic pathways and treatment options available.
https://tomoclinic.ua/cancers/rak-molochnoyi-zalozy/
